TMDX(TransMedics Group, Inc.) · 财务报表

TMDX(TransMedics Group, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$30.26M$93.46M$241.62M$441.54M$605.49M
毛利润$21.16M$65.27M$154.09M$262.08M$362.81M
营业利润−$39.43M−$31.44M−$28.73M$37.50M$108.58M
净利润−$44.22M−$36.23M−$25.03M$35.46M$190.29M
经营现金流−$28.86M−$45.82M−$13.03M$48.80M$192.84M
自由现金流−$32.38M−$57.72M−$164.88M−$80.94M$133.59M
摊薄每股收益$-1.60$-1.23$-0.77$1.01$4.87

TransMedics Group, Inc. TMDX